About Anti Cancer Injection
In Anti Cancer Medicine we are offering formulation of api Amifostine tablets , Vial Lyophilised tablets , Anastrozole (Breast Cancer) tablets , Bicalutamide tablets , Bleomycin tablets , Busulfan tablets , Capecitabine tablets ,Doxorubicin tablets , Carboplatin tablets , Chlorambucil tablets , Cisplatin tablets , Cyclophosphamide tablets , Cytarabine tablets , Dacarbazine tablets , Dactinomycin tablets , Docetaxel tablets , Epirubicin tablets , Etoposide tablets , Fludarabine Phosphate tablets , Fluorouracil tablets , Flutamide tablets , Gefitinib tablets , Gemcitabine tablets , Hydroxyurea tablets , Idarubicin tablets , Ifosfamide tablets , Imatinib Mesylate tablets , Irinotecan tablets , L-Asparaginase tablets , Lenalidomide tablets , Letrozole tablets , Leucovorin Calcium tablets , Levamisole tablets , Lomustine Capsules, Megestrol tablets etcin different combination & dosage form like tablets ( sugar coated/ enteric coated/ film coated/ extended release/ slow release/ dispersible tablets/ effervescent tablets), capsule, injection, creams, ointment, syrup, ampoule, liquid tonics, powder, sachets, granules, ors powder etc.
High Standards of Manufacturing and SterilityProduced in GMP-certified plants, each injection undergoes stringent sterility protocols, resulting in a single-use preparation. The vial comes with specified batch number and bar code, ensuring traceability and safety in clinical use. Compliance with USFDA and WHO standards underlines the dedication to quality and patient safety.
Tailored Formulation for Cancer TreatmentComposed of purified anti-cancer agents, this injection is designed as an allopathic prescription medication for patients diagnosed with specific types of cancer. The dosage strength varies according to indication, offering targeted therapeutic efficacy essential for oncology care.
Convenient Packaging and AdministrationEach box contains one vial, making usage straightforward for hospital pharmacies and oncology centers. The administration route is either intravenous or intramuscular, allowing flexibility for oncologists to optimize dosing based on patient requirements and cancer type.
FAQs of Anti Cancer Injection:
Q: How is the anti-cancer injection administered to patients?
A: The injection is given either intravenously or intramuscularly, as determined by a physician, in hospital or oncology center settings to ensure proper monitoring and safety.
Q: What are the main benefits of this anti-cancer injection?
A: It delivers potent anti-neoplastic agents directly to the bloodstream, maximizing therapeutic efficacy against cancer cells while adhering to strict sterility and regulatory standards.
Q: When should this medication be used during cancer therapy?
A: Usage is strictly as prescribed by an oncologist, typically within a scheduled chemotherapy protocol for specific types of cancer, depending on patient diagnosis and treatment plan.
Q: Where should the injection be stored before administration?
A: The vial should be kept in a cool, dry, and dark place to preserve its efficacy until use, as stated in the storage instructions.
Q: What is the process for confirming product authenticity and specifications?
A: Each vial carries a batch number and bar code, along with manufacturer label details and GMP certification, allowing medical staff and suppliers to confirm authenticity and regulatory compliance.
Q: Is a prescription required for this anti-cancer injection?
A: Yes, it is a prescription-only medication and must be administered under the direct supervision of a qualified oncologist or healthcare professional.
Q: Who should avoid using this injection?
A: This injection is contraindicated for patients with known hypersensitivity to any component of the formulation, as noted in the product specifications.